Stella Matsuda, MD
Dermatology · Honolulu, HINPI 1528106671
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,523 of the $9,448 with a category attached, or 79.6%. 26 manufacturers reported payments, led by AbbVie at 28.3% of the total.
Across 306 payments — averaging $30.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Galderma Laboratories, L.p.$919
- Merz North America, Inc.$848
- Lilly USA, LLC$714
- Regeneron Healthcare Solutions, Inc.$714
- Amgen$516
- plus $3K from 20 others
What the payments were for
- Speaking & faculty fees$1,80819%
- Food & beverage$7,52380%
- Education$1171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 79 | $2,670 |
| Galderma Laboratories, L.p. | 20 | $919 |
| Merz North America, Inc. | 12 | $848 |
| Lilly USA, LLC | 26 | $714 |
| Regeneron Healthcare Solutions, Inc. | 22 | $714 |
| Amgen | 24 | $516 |
| UCB, Inc. | 19 | $419 |
| Sanofi | 13 | $387 |
| Novartis | 14 | $356 |
| Incyte Corporation | 8 | $271 |
| Sun Pharmaceutical Industries Inc. | 11 | $251 |
| E.r. Squibb & Sons, L.L.C. | 10 | $245 |
| LEO Pharma Inc. | 8 | $196 |
| Solta Medical, A Division Of Bausch Health US, LLC | 8 | $160 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $160 |
| Bristol Myers Squibb | 7 | $144 |
| Biofrontera Inc. | 4 | $83 |
| Arcutis Biotherapeutics, Inc. | 3 | $74 |
| Genentech USA, Inc. | 3 | $62 |
| Pfizer | 3 | $56 |
| Organon | 2 | $54 |
| Johnson & Johnson | 2 | $50 |
| Dermira, Inc. | 1 | $28 |
| Journey Medical Corporation | 1 | $28 |
| Revance Therapeutics, Inc. | 1 | $28 |
| VYNE Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SILIQ$121
How this compares
$9,448 in reported general payments places this provider in the 75th percentile of 67 dermatology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 34 | $127,394 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 12 | $87,004 |
| Mycophenolate Mofetil | 18 | $23,051 |
| Tacrolimus | 29 | $8,083 |
| Clobetasol Propionate | 24 | $1,711 |
| Metronidazole | 11 | $1,465 |
| Fluocinonide | 29 | $936 |
| Doxycycline Hyclate | 15 | $711 |
| Ketoconazole | 39 | $651 |
| Triamcinolone Acetonide | 71 | $650 |
| Halobetasol Propionate | 12 | $553 |
| Fluocinolone Acetonide | 12 | $454 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 46 | $391 |
| Spironolactone | 12 | $145 |
| Prednisone | 11 | $94 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Honolulu
- Sarah HowellHonolulu$653K
- Douglas JohnsonHonolulu$568K
- Ryan SatoHonolulu$226K
- Greg SakamotoHonolulu$20K
- Kory KitagawaHonolulu$18K
- Kevin DawsonHonolulu$16K
- Dylan LeeHonolulu$15K
- Sarah GrekinHonolulu$13K
- Gregory HerbichHonolulu$12K
- Aaron FongHonolulu$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.